SCHEMBL4902469

SCHEMBL4902469

CCN(c1coc(-c2ccc(C(C)(C)C)cc2)n1)S(=O)(=O)c1ccc(C(C)C)c(C(=O)OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.39
HDAC3 O15379 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
PKM P14618 1/20 0.35
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TRPM8 Q7Z2W7 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
USP2 O75604 1/20 0.33
HCRTR2 O43614 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895934 0.91 LMNA (0.40) ALDH1A1HDAC3HDAC11HDAC8HDAC6
SCHEMBL4906002 0.89 ALDH1A1 (0.39) ALDH1A1TSHRHDAC3HDAC11HDAC8
SCHEMBL4900715 0.89 ALDH1A1 (0.39) ALDH1A1TSHRHDAC3HDAC11HDAC8
SCHEMBL4895724 0.85 PPARG (0.38) ALDH1A1TSHRHDAC3HDAC11HDAC8
SCHEMBL4897582 0.82 LMNA (0.40) ALDH1A1HDAC3HDAC11HDAC8HDAC6
SCHEMBL4899823 0.82 LMNA (0.40) ALDH1A1HDAC3HDAC11HDAC8HDAC6
SCHEMBL4903608 0.81 PPARG (0.41) ALDH1A1TSHRHDAC3HDAC11HDAC8
SCHEMBL4906847 0.81 ALDH1A1 (0.38) ALDH1A1TSHRHDAC3HDAC11HDAC8
SCHEMBL4895904 0.79 ALDH1A1 (0.39) ALDH1A1TSHRHDAC3HDAC11HDAC8
SCHEMBL4902454 0.78 LMNA (0.38) ALDH1A1PPARGPPARALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885HDAC3 176/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885HDAC3 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.